Skip to Content
You are currently on the new version of our website. Access the old version .

4,064 Results Found

  • Article
  • Open Access
25 Citations
6,185 Views
19 Pages

KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells

  • Juan Li,
  • Baotong Zhang,
  • Mingcheng Liu,
  • Xing Fu and ,
  • Xinpei Ci,
  • Jun A,
  • Changying Fu,
  • Ge Dong,
  • Rui Wu and
  • Jin-Tang Dong
  • + 7 authors+ 2 authors

21 March 2020

Androgen/androgen receptor (AR) signaling drives both the normal prostate development and prostatic carcinogenesis, and patients with advanced prostate cancer often develop resistance to androgen deprivation therapy. The transcription factor Krü...

(This article belongs to the Special Issue Urological Cancer 2020)
  • Communication
  • Open Access
23 Citations
5,956 Views
19 Pages

Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level

  • Aline Rangel-Pozzo,
  • Songyan Liu,
  • Gabriel Wajnberg,
  • Xuemei Wang and ,
  • Rodney J. Ouellette,
  • Geoffrey G. Hicks,
  • Darrel Drachenberg and
  • Sabine Mai
  • + 3 authors+ 0 author

8 August 2020

Accurate risk classification of men with localized high-risk prostate cancer directly affects treatment management decisions and patient outcomes. A wide range of risk assessments and classifications are available. However, each one has significant l...

(This article belongs to the Special Issue Single Cell Analysis)
  • Case Report
  • Open Access
4 Citations
3,441 Views
7 Pages

Mixed Adenosquamous Cell Carcinoma of the Prostate with Paired Sequencing on the Primary and Liver Metastasis

  • Emmanuella Oyogoa,
  • Maya Sonpatki,
  • Brian T. Brinkerhoff,
  • Nicole Andeen and ,
  • Haley Meyer,
  • Christopher Ryan and
  • Alexandra O. Sokolova
  • + 2 authors+ 0 author

24 April 2024

This report aims to shed light on the intricate challenges encountered during the diagnosis and treatment of an uncommon variant of prostate cancer—mixed adenosquamous cell carcinoma of the prostate. Prostate cancers of this nature pose distinc...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume)
  • Article
  • Open Access
3 Citations
3,282 Views
15 Pages

Prostate cancer chemoresistance is a major therapeutic problem, and the underlying mechanism is not well understood and effective therapies to overcome this problem are not available. Phosphodiesterase-4 (PDE4), a main intracellular enzyme for cAMP h...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
32 Citations
8,450 Views
14 Pages

Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer

  • Kaile Zhang,
  • Shukui Zhou,
  • Leilei Wang,
  • Jianlong Wang and ,
  • Qingsong Zou,
  • Weixin Zhao,
  • Qiang Fu and
  • Xiaolan Fang
  • + 3 authors+ 0 author

Currently there is little effective treatment available for castration resistant prostate cancer, which is responsible for the majority of prostate cancer related deaths. Emerging evidence suggested that cancer stem cells might play an important role...

(This article belongs to the Special Issue Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer)
  • Article
  • Open Access
783 Views
18 Pages

26 February 2026

Canine prostatic adenocarcinoma is a rare but highly aggressive cancer that is typically diagnosed at an advanced stage, due to the lack of effective screening methods and poor recognition of early lesions. Cancer stem cells are known to drive tumour...

(This article belongs to the Section Companion Animals)
  • Review
  • Open Access
8 Citations
7,044 Views
45 Pages

CAR-T Cell Therapy for Prostate Cancer: Current Advances and Future Perspectives

  • Maria Luisa Calabrò,
  • Roberta Ettari,
  • Carla Di Chio,
  • Fabiola De Luca and ,
  • Santo Previti and
  • Maria Zappalà
  • + 1 author+ 0 author

Prostate cancer is the most frequently diagnosed solid-organ malignancy in men worldwide. Metastatic castration-resistant prostate cancer represents a rapidly fatal, end-stage form of the disease for which current therapies remain palliative rather t...

(This article belongs to the Section Gene and Cell Therapy)
  • Abstract
  • Open Access
2 Citations
2,093 Views
1 Page

Prostate cancer is one of the cause of mortality and morbidity in men. High nutritional quality mushrooms have been consumed as food for a long time and Thanks to their bioactive components, they can be used in many fields such as pharmaceuticals, co...

(This article belongs to the Proceedings of The 3rd International conference on Natural Products for Cancer Prevention and Therapy)
  • Review
  • Open Access
26 Citations
6,978 Views
11 Pages

Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes

  • Salvatore Cozzi,
  • Lilia Bardoscia,
  • Masoumeh Najafi,
  • Andrea Botti and ,
  • Gladys Blandino,
  • Matteo Augugliaro,
  • Moana Manicone,
  • Federico Iori,
  • Lucia Giaccherini and
  • Patrizia Ciammella
  • + 7 authors+ 2 authors

9 March 2022

Adenoid cystic carcinoma/basaloid cell carcinoma of the prostate (ACC/BCC) is a very rare variant of prostate cancer with uncertain behavior. Few cases are reported in the literature. Data on treatment options are scarce. The aim of our work was to r...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment)
  • Article
  • Open Access
4 Citations
2,975 Views
17 Pages

Peptide Modification Diminishes HLA Class II-restricted CD4+ T Cell Recognition of Prostate Cancer Cells

  • Bently P. Doonan,
  • Shereen Amria,
  • Jennifer R. Bethard,
  • Narendra L. Banik and ,
  • Jessica D. Hathaway-Schrader and
  • Azizul Haque
  • + 1 author+ 0 author

3 December 2022

Prostate cancer poses an ongoing problem in the western world accounting for significant morbidity and mortality in the male population. Current therapy options are effective in treating most prostate cancer patients, but a significant number of pati...

(This article belongs to the Special Issue Inflammation in Health and Disease: New Insights and Therapeutic Avenues 2.0)
  • Article
  • Open Access
21 Citations
7,943 Views
10 Pages

27 April 2012

Quantum dots (QDs) are a new class of fluorescent labeling for biological and biomedical applications. In this study, we detected prostate stem cell antigen (PSCA) expression correlated with tumor grade and stage in human prostate cancer by QDs-based...

(This article belongs to the Special Issue Optical Sensors in Medicine)
  • Case Report
  • Open Access
14 Citations
5,165 Views
4 Pages

Primary Signet Ring Cell Carcinoma of the Prostate: A Rare Case Report

  • Alper Gök,
  • Can Tuygun,
  • Müge Akmansu,
  • Ayşegül Aksakal Uslu and ,
  • Ibrahim Güven Kartal,
  • Fatih Sandikçi,
  • Osman Raif Karabacak,
  • Azmi Levent Sağnak,
  • Hikmet Topaloğlu and
  • Hamit Ersoy
  • + 5 authors+ 0 author

15 August 2018

Primary prostatic signet ring cell carcinoma is a rare form of cancer with a poor prognosis, which is generally treated with a traditional prostate adenocarcinoma therapy. This case report presents a 70-year-old diagnosed with primary prostatic signe...

(This article belongs to the Section Oncology)
  • Abstract
  • Open Access
1 Citations
3,714 Views
1 Page

15 November 2017

Deaths resulting from prostate cancer are due to metastases rather than primary tumor. Therefore, understanding metastatic mechanisms play a significant role. It has been determined that metastatic progression can be avoided by the voltage-gated sodi...

(This article belongs to the Proceedings of Proceedings of the 2nd International Conference on Natural Products for Cancer Prevention and Therapy)
  • Article
  • Open Access
3 Citations
2,810 Views
27 Pages

Secretome Analysis of Prostate Cancer Cell Lines Reveals Cell Cycle-Dependent PSA Secretion and Potential Biomarkers

  • Eshwari Dathathri,
  • Yvette Peters,
  • Diana Andreoli,
  • Mel Bruins and ,
  • Jaco Kraan,
  • Leon W. M. M. Terstappen and
  • Ruchi Bansal
  • + 2 authors+ 0 author

20 February 2025

Background: Metastatic prostate cancer (mPCa) is marked by heterogeneity and therapy resistance, which arise from prolonged therapy regimens. This heterogeneity is reflected in various morphologic and genetic characteristics, biomarker expression, an...

(This article belongs to the Special Issue Clinical Treatment and Prognostic Factors of Urologic Cancer)
  • Article
  • Open Access
1 Citations
3,890 Views
17 Pages

Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers

  • Vladimir M. Ryabov,
  • Mikhail M. Baryshev,
  • Mikhail A. Voskresenskiy and
  • Boris V. Popov

1 February 2023

Prostate cancer (PCa) is a widespread oncological disease that proceeds in the indolent form in most patients. However, in some cases, the indolent form can transform into aggressive metastatic incurable cancer. The most important task of PCa diagnos...

(This article belongs to the Special Issue Prostate Cancer: Pathology, Pathobiology and Therapy)
  • Review
  • Open Access
50 Citations
5,962 Views
24 Pages

Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer

  • Mahasha P.J. Perera,
  • Patrick B. Thomas,
  • Gail P. Risbridger,
  • Renea Taylor and ,
  • Arun Azad,
  • Michael S. Hofman,
  • Elizabeth D. Williams and
  • Ian Vela
  • + 3 authors+ 0 author

20 January 2022

Prostate cancer is the most commonly diagnosed solid-organ cancer amongst males worldwide. Metastatic castrate-resistant prostate cancer (mCRPC) is a rapidly fatal end-sequelae of prostate cancer. Therapeutic options for men with mCRPC are limited an...

  • Article
  • Open Access
15 Citations
6,623 Views
20 Pages

Keratin Profiling by Single-Cell RNA-Sequencing Identifies Human Prostate Stem Cell Lineage Hierarchy and Cancer Stem-Like Cells

  • Wen-Yang Hu,
  • Dan-Ping Hu,
  • Lishi Xie,
  • Larisa Nonn and ,
  • Ranli Lu,
  • Michael Abern,
  • Toshihiro Shioda and
  • Gail S. Prins
  • + 3 authors+ 0 author

Single prostate stem cells can generate stem and progenitor cells to form prostaspheres in 3D culture. Using a prostasphere-based label retention assay, we recently identified keratin 13 (KRT13)-enriched prostate stem cells at single-cell resolution,...

(This article belongs to the Special Issue Cancer Stem Cells in Basic Science and in Translational Oncology)
  • Article
  • Open Access
21 Citations
4,045 Views
19 Pages

Dual Effect of Tryptamine on Prostate Cancer Cell Growth Regulation: A Pilot Study

  • Zhuangzhuang Li,
  • Baoyan Ding,
  • Mustafa R. K. Ali,
  • Lizhen Zhao and ,
  • Xiaoling Zang and
  • Zhihua Lv
  • + 1 author+ 0 author

21 September 2022

Abnormal tryptophan metabolism is linked to cancer and neurodegenerative diseases, and tryptophan metabolites have been reported as potential prostate cancer (PCa) biomarkers. However, little is known about the bioactivities of tryptophan metabolites...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
47 Citations
11,620 Views
23 Pages

Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer

  • Diana C. Simão,
  • Kevin K. Zarrabi,
  • José L. Mendes,
  • Ricardo Luz and ,
  • Jorge A. Garcia,
  • William K. Kelly and
  • Pedro C. Barata
  • + 2 authors+ 0 author

23 February 2023

Over the past decade, immunotherapy has demonstrated an impressive improvement in treatment outcomes for multiple cancers. Following the landmark approvals for use of immune checkpoint inhibitors, new challenges emerged in various clinical settings....

(This article belongs to the Collection Urological Cancer 2023-2025)
  • Article
  • Open Access
25 Citations
7,062 Views
11 Pages

Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3

  • Miguel Cabello,
  • Haobo Ge,
  • Carmen Aracil,
  • Despina Moschou and ,
  • Pedro Estrela,
  • Jose Manuel Quero,
  • Sofia I. Pascu and
  • Paulo R. F. Rocha
  • + 3 authors+ 0 author

3 January 2019

Although prostate cancer is one of the most common cancers in the male population, its basic biological function at a cellular level remains to be fully understood. This lack of in depth understanding of its physiology significantly hinders the devel...

(This article belongs to the Special Issue Sensors for Cell Analysis)
  • Article
  • Open Access
27 Citations
8,244 Views
13 Pages

Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest

  • Han Jin Cho,
  • Do Young Lim,
  • Gyoo Taik Kwon,
  • Ji Hee Kim and ,
  • Zunnan Huang,
  • Hyerim Song,
  • Yoon Sin Oh,
  • Young-Hee Kang,
  • Ki Won Lee and
  • Jung Han Yoon Park
  • + 6 authors+ 1 author

22 February 2016

Benzyl isothiocyanate (BITC) is a hydrolysis product of glucotropaeolin, a compound found in cruciferous vegetables, and has been shown to have anti-tumor properties. In the present study, we investigated whether BITC inhibits the development of pros...

(This article belongs to the Special Issue The Mechanism of Action of Food Components in Disease Prevention)
  • Article
  • Open Access
1 Citations
1,950 Views
10 Pages

Metastatic prostate cancer occurs when the tumor spreads from the prostate gland to other parts of the body. Previous studies have shown that Gαi2, a subunit of the heterotrimeric G protein complex, plays a critical role in inducing cell migrat...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
18 Citations
4,781 Views
23 Pages

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment

  • Linda K. H. Teng,
  • Brooke A. Pereira,
  • Shivakumar Keerthikumar,
  • Cheng Huang and ,
  • Birunthi Niranjan,
  • Sophie N. Lee,
  • Michelle Richards,
  • Ralf B. Schittenhelm,
  • Luc Furic and
  • Natalie L. Lister
  • + 10 authors+ 5 authors

11 March 2021

Mast cells (MCs) are important cellular components of the tumor microenvironment and are significantly associated with poor patient outcomes in prostate cancer and other solid cancers. The promotion of tumor progression partly involves heterotypic in...

(This article belongs to the Special Issue Microenvironment and Cancer Progression)
  • Article
  • Open Access
6 Citations
5,716 Views
19 Pages

Genomic Characterization of Preclinical Prostate Cancer Cell Line Models

  • Erica L. Beatson,
  • Emily N. Risdon,
  • Giulia C. Napoli,
  • Douglas K. Price and ,
  • Cindy H. Chau and
  • William D. Figg
  • + 1 author+ 0 author

As we move into the era of precision medicine, the growing relevance of genetic alterations to prostate cancer (PCa) development and treatment demonstrates the importance of characterizing preclinical models at the genomic level. Our study investigat...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
86 Citations
9,585 Views
16 Pages

Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer

  • Isabella Monia Montagner,
  • Alessandro Penna,
  • Giulio Fracasso,
  • Debora Carpanese and ,
  • Anna Dalla Pietà,
  • Vito Barbieri,
  • Gaia Zuccolotto and
  • Antonio Rosato
  • + 3 authors+ 0 author

2 June 2020

Prostate cancer (PCa) has become the most common cancer among males in Europe and the USA. Adoptive immunotherapy appears a promising strategy to control the advanced stages of the disease by specifically targeting the tumor, in particular through ch...

(This article belongs to the Special Issue New Developments of Natural Killer (NK) Cells in Immunotherapy)
  • Article
  • Open Access
2 Citations
2,705 Views
18 Pages

Locus-Specific Bisulfate NGS Sequencing of GSTP1, RNF219, and KIAA1539 Genes in the Total Pool of Cell-Free and Cell-Surface-Bound DNA in Prostate Cancer: A Novel Approach for Prostate Cancer Diagnostics

  • Olga Bryzgunova,
  • Anna Bondar,
  • Pavel Ruzankin,
  • Anton Tarasenko and ,
  • Marat Zaripov,
  • Marsel Kabilov and
  • Pavel Laktionov
  • + 2 authors+ 0 author

9 January 2023

The locus-specific methylation of three genes (GSTP1, RNF219, and KIAA1539, also known as FAM214B) in the total pool of blood cell-free DNA, including cell-free DNA from plasma and cell-surface-bound DNA, of patients with prostate cancer and healthy...

  • Article
  • Open Access
4 Citations
3,548 Views
12 Pages

Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress

  • Philippa Lantwin,
  • Adam Kaczorowski,
  • Cathleen Nientiedt,
  • Constantin Schwab and ,
  • Martina Kirchner,
  • Viktoria Schütz,
  • Magdalena Görtz,
  • Markus Hohenfellner,
  • Anette Duensing and
  • Stefan Duensing
  • + 6 authors+ 1 author

28 March 2024

Introduction: DNA damage repair gene deficiency defines a subgroup of prostate cancer patients with early metastatic progression and unfavorable disease outcome. Whether deficiency in DNA damage repair genes directly promotes metastatic dissemination...

  • Article
  • Open Access
3 Citations
4,767 Views
22 Pages

1,25-Dihydroxyvitamin D3 Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line

  • Jabril R. Johnson,
  • Rachel N. Martini,
  • Yate-Ching Yuan,
  • Leanne Woods-Burnham and ,
  • Mya Walker,
  • Greisha L. Ortiz-Hernandez,
  • Firas Kobeissy,
  • Dorothy Galloway,
  • Amani Gaddy and
  • Rick A. Kittles
  • + 12 authors+ 7 authors

15 May 2024

Vitamin D3 is a steroid hormone that confers anti-tumorigenic properties in prostate cells. Serum vitamin D3 deficiency has been associated with advanced prostate cancer (PCa), particularly affecting African American (AA) men. Therefore, elucidating...

(This article belongs to the Special Issue Cancer and Signalling: Targeting Cellular Pathways)
  • Case Report
  • Open Access
1,397 Views
6 Pages

14 February 2026

Background and Clinical Significance: Prostatic malignancies are amongst the leading malignancies in incidence. They represent a mixed group of conditions, predominantly characterized by adenocarcinomas, which are themselves predominantly acinar. Cas...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
1,896 Views
26 Pages

HSP90α and KLK6 Coregulate Stress-Induced Prostate Cancer Cell Motility

  • Katelyn L. O’Neill,
  • Johnny W. Zigmond and
  • Raymond Bergan

16 January 2026

Prostate cancer (PCa) metastasis is reliant on the activity of proteases, such as matrix metalloproteinase-2 (MMP-2). While increased extracellular heat shock protein 90α (eHSP90α) has been linked to increased MMP-2 activity, this has not...

(This article belongs to the Section Cell Motility and Adhesion)
  • Communication
  • Open Access
13 Citations
4,377 Views
22 Pages

14 August 2019

Patient-specific assessment, disease monitoring, and the development of an accurate early surrogate of the therapeutic efficacy of locally advanced prostate cancer still remain a clinical challenge. Contrary to prostate biopsies, circulating tumor ce...

(This article belongs to the Special Issue Liquid Biopsy for Cancer)
  • Review
  • Open Access
22 Citations
6,018 Views
23 Pages

Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer

  • Samantha Gogola,
  • Michael Rejzer,
  • Hisham F. Bahmad,
  • Ferial Alloush and ,
  • Yumna Omarzai and
  • Robert Poppiti
  • + 1 author+ 0 author

6 March 2023

Prostate cancer (PCa) is the second-most commonly diagnosed cancer in men around the world. It is treated using a risk stratification approach in accordance with the National Comprehensive Cancer Network (NCCN) in the United States. The main treatmen...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
4 Citations
7,939 Views
16 Pages

Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer

  • Jo A. Tucker,
  • Caroline Jochems,
  • James L. Gulley,
  • Jeffrey Schlom and
  • Kwong Y. Tsang

11 December 2012

Active immunotherapy is dependent on the ability of the immune system to recognize and respond to tumors. Despite overwhelming evidence to support a cell-mediated immune response to prostate cancer, it is insufficient to eradicate the disease. This i...

(This article belongs to the Special Issue Immune Responses to Human Prostate Cancer)
  • Article
  • Open Access
31 Citations
5,501 Views
21 Pages

28 February 2021

Prostate cancer is one of the most common cancers in men. Cell invasion is an important step in the process of cancer metastasis. Herein, gold nanorods (GNRs) and polyethylene glycol (PEG)-coated GNRs were conjugated with polydopamine (PDA). The PDA-...

(This article belongs to the Special Issue Inorganic Nanoparticles in Biomedical Applications)
  • Article
  • Open Access
20 Citations
5,486 Views
17 Pages

miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells

  • Willian A. da Silveira,
  • Ludivine Renaud,
  • Edward S. Hazard and
  • Gary Hardiman

24 January 2022

Cellular senescence is a state of permanent growth arrest that arises once cells reach the limit of their proliferative capacity. It creates an inflammatory microenvironment favouring the initiation and progression of various age-related diseases, in...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
14 Citations
2,749 Views
12 Pages

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis

  • Philipp Krausewitz,
  • Niklas Kluemper,
  • Ayk-Peter Richter,
  • Thomas Büttner and ,
  • Glen Kristiansen,
  • Manuel Ritter and
  • Jörg Ellinger
  • + 2 authors+ 0 author

7 September 2022

Background: The methylation status of Septin 9 (SEPT9) and short stature homeobox 2 (SHOX2) in circulating cell-free DNA (ccfDNA) are validated pan-cancer biomarkers. The present proof-of-concept study aimed to investigate the potential and dynamics...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
9 Citations
4,094 Views
19 Pages

Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5

  • Franziska Striese,
  • Christin Neuber,
  • Sandy Gräßel,
  • Claudia Arndt and ,
  • Martin Ullrich,
  • Jörg Steinbach,
  • Jens Pietzsch,
  • Ralf Bergmann,
  • Hans-Jürgen Pietzsch and
  • Michael P. Bachmann
  • + 8 authors+ 3 authors

Prostate specific membrane antigen (PSMA) is an excellent target for imaging and treatment of prostate carcinoma (PCa). Unfortunately, not all PCa cells express PSMA. Therefore, alternative theranostic targets are required. The membrane protein prost...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
4 Citations
3,580 Views
18 Pages

Transcriptomic Profiling Analysis of Castration-Resistant Prostate Cancer Cell Lines Treated with Chronic Intermittent Hypoxia

  • Chung Lyul Lee,
  • Minji Lee,
  • Ji Yong Lee,
  • Sin-hyoung Hong and ,
  • Seung Woo Yang,
  • Ji-hyeon Min,
  • Dong-eon Lee,
  • Joonyoung Baek,
  • Chanseul Kim and
  • Gun-Hwa Kim
  • + 8 authors+ 3 authors

16 August 2022

Castration-resistant prostate cancer (CRPC) is still a major concern in men’s health, with 375,000 cancer deaths annually. Hypoxia, which is a marked characteristic of advanced solid tumors, has been suggested to induce prostate cancer towards...

(This article belongs to the Special Issue Prostate Cancer Metastasis)
  • Article
  • Open Access
77 Citations
9,118 Views
24 Pages

Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells

  • Takanori Eguchi,
  • Chiharu Sogawa,
  • Kisho Ono,
  • Masaki Matsumoto and ,
  • Manh Tien Tran,
  • Yuka Okusha,
  • Benjamin J. Lang,
  • Kuniaki Okamoto and
  • Stuart K. Calderwood
  • + 4 authors+ 0 author

19 March 2020

Tumor cells exhibit therapeutic stress resistance-associated secretory phenotype involving extracellular vesicles (EVs) such as oncosomes and heat shock proteins (HSPs). Such a secretory phenotype occurs in response to cell stress and cancer therapeu...

(This article belongs to the Special Issue Molecular Chaperones: Cancer and Cell Death)
  • Article
  • Open Access
10 Citations
4,881 Views
19 Pages

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer

  • Michael Ladurner,
  • Manuel Wieser,
  • Andrea Eigentler,
  • Martin Seewald and ,
  • Gabriele Dobler,
  • Hannes Neuwirt,
  • Mona Kafka,
  • Isabel Heidegger,
  • Wolfgang Horninger and
  • Iris E. Eder
  • + 8 authors+ 3 authors

Since tissue material is often lacking in metastatic prostate cancer (mPCa), there is increasing interest in using liquid biopsies for treatment decision and monitoring therapy responses. The purpose of this study was to validate the usefulness of ci...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
2 Citations
3,243 Views
20 Pages

A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase

  • Jessica A. Wright,
  • Stephanie D. White,
  • Gavin Frame,
  • Ana Bosiljkov and ,
  • Shahbaz Khan,
  • Roni Haas,
  • Qian Yang,
  • Minzhi Sheng,
  • Xiaoyong Huang and
  • Stanley K. Liu
  • + 14 authors+ 9 authors

31 May 2025

Prostate cancer cell lines are particularly clinically homogenous, mostly representing metastatic states rather than localized disease. While there has been significant work in the development of additional models, few have been created without oncog...

(This article belongs to the Section Cellular Pathology)
  • Review
  • Open Access
1 Citations
1,004 Views
14 Pages

The Role of PET Tracers in Small-Cell Prostate Cancer (SCPC): An Overview in Clinical and Preclinical Settings

  • Flaminia Vocaturo,
  • Silvia Taralli,
  • Valentina Scolozzi,
  • Lucia Leccisotti and
  • Carmelo Caldarella

20 May 2026

Background/Objectives: Small-cell prostate cancer (SCPC) is a rare, aggressive variant of prostate cancer with poor prognosis, arising “de novo” or through lineage plasticity from conventional adenocarcinoma under androgen receptor-target...

(This article belongs to the Special Issue Advances in the Use of PET/CT and MRI in Prostate Cancer: 2nd Edition)
  • Article
  • Open Access
9 Citations
5,148 Views
37 Pages

Low Magnetic Field Exposure Alters Prostate Cancer Cell Properties

  • Sigrun Lange,
  • Jameel M. Inal,
  • Igor Kraev,
  • Dafydd Alwyn Dart and
  • Pinar Uysal-Onganer

19 September 2024

Prostate cancer is the second most common neoplasia and fifth-leading cause of cancer death in men worldwide. Electromagnetic and magnetic fields have been classified as possible human carcinogens, but current understanding of molecular and cellular...

(This article belongs to the Special Issue The Rules of Life Rethought: Latest Progress in Quantum Biology)
  • Article
  • Open Access
39 Citations
5,827 Views
16 Pages

Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics

  • Shiv Verma,
  • Eswar Shankar,
  • F. Naz Cemre Kalayci,
  • Amrita Mukunda and ,
  • Malek Alassfar,
  • Vaibhav Singh,
  • E. Ricky Chan,
  • Gregory T. MacLennan and
  • Sanjay Gupta
  • + 4 authors+ 0 author

16 December 2020

Enzalutamide, an antiandrogen, is approved for therapy of castration resistant prostate cancer. Clinical applications have shown that approximately 30% of patients acquire resistance after a short period of treatment. However, the molecular mechanism...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
18 Citations
6,781 Views
19 Pages

Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies

  • Sabrina Bossio,
  • Anna Perri,
  • Raffaella Gallo,
  • Anna De Bartolo and ,
  • Vittoria Rago,
  • Daniele La Russa,
  • Michele Di Dio,
  • Sandro La Vignera,
  • Aldo E. Calogero and
  • Antonio Aversa
  • + 6 authors+ 1 author

4 December 2023

Alpha-lipoic acid (ALA) is a natural antioxidant dithiol compound, exerting antiproliferative and antimetastatic effects in various cancer cell lines. In our study, we demonstrated that ALA reduces the cell growth of prostate cancer cells LNCaP and D...

(This article belongs to the Special Issue Bioactive Compounds and Therapeutic Targets in Prostate Cancer)
  • Article
  • Open Access
2 Citations
2,217 Views
25 Pages

2 April 2026

Prostate cancer is one of the most prevalent malignancies among men and remains a major clinical challenge due to the complex tumor microenvironment. Understanding gene expression dynamics at both cellular and spatial levels is essential for improvin...

(This article belongs to the Special Issue The Spatial and Temporal Dynamics of the Tumor Microenvironment)
  • Brief Report
  • Open Access
2 Citations
2,550 Views
8 Pages

Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation

  • Michele Iuliani,
  • Sonia Simonetti,
  • Giulia Ribelli,
  • Silvia Cavaliere and ,
  • Bruno Vincenzi,
  • Giuseppe Tonini,
  • Francesco Pantano and
  • Daniele Santini
  • + 3 authors+ 0 author

Abiraterone is a selective inhibitor of androgen biosynthesis approved for the treatment of metastatic patients affected by castration-resistant or castration-sensitive prostate cancer. Intriguingly, clinical data revealed that abiraterone also delay...

(This article belongs to the Special Issue Cancer Metastasis and Therapeutic Resistance)
  • Review
  • Open Access
790 Views
28 Pages

22 June 2026

Prostate cancer remains a major therapeutic challenge, particularly after progression to castration-resistant disease, where persistent androgen receptor signaling, metabolic adaptation, immune escape, and treatment resistance jointly limit clinical...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
10 Citations
3,741 Views
14 Pages

Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients

  • Yoko Koh,
  • Matias A. Bustos,
  • Jamie Moon,
  • Rebecca Gross and ,
  • Romela Irene Ramos,
  • Suyeon Ryu,
  • Jane Choe,
  • Selena Y. Lin,
  • Warren M. Allen and
  • Dave S. B. Hoon
  • + 7 authors+ 2 authors

12 May 2022

Prostate cancer (PCa) is the most common cancer in men. Prostate-specific antigen screening is recommended for the detection of PCa. However, its specificity is limited. Thus, there is a need to find more reliable biomarkers that allow non-invasive s...

(This article belongs to the Special Issue The 5th ACTC: “Liquid Biopsy in Its Best”)
  • Article
  • Open Access
7 Citations
4,488 Views
22 Pages

15 September 2021

Background: Despite its widespread use, the use of prostate-specific antigen (PSA) alone as a screening biomarker for prostate cancer (PCa) leads often to unwarranted prostate biopsy, over-diagnosis, and consequently, over-treatment, because of its l...

(This article belongs to the Special Issue Signaling Pathways and Targeted Molecular Therapy in Prostate Cancer)

of 82